PharmaVoice
JULY 13, 2022
Elizabeth Izard Apelles is finding innovative ways to champion rare disease patients through an emerging platform from Honeycomb Health.
Pharmacy Times
JULY 13, 2022
The FDA's current way of inspecting facilities for quality control is badly outdated and is politically unworkable, unreliable, and unsafe.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
JULY 13, 2022
How the chief commercial and corporate strategy officer is embracing a ‘full-cup’ philosophy to build a better leadership toolbox.
Pharmacy Times
JULY 13, 2022
Bunch Pharmacy has been in business for 24 years in the rural area of Alabama.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
JULY 13, 2022
New York’s attorney general has accused Teva of lying to evade responsibility for its alleged role in fuelling the opioid epidemic in the state and is asking for a case against the company to be reopened. AG Letitia James says the Israeli drugmaker “made significant and intentional misrepresentations” to her office and the court about its involvement with its US subsidiary in order to evade legal action and accountability.
Pharmacy Times
JULY 13, 2022
With a coordinated, interprofessional team supporting them, patients are empowered with information at the point-of-care to help manage medication therapy problems as they arise.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
JULY 13, 2022
Community pharmacists are vulnerable to security threats, resulting in bad outcomes for both patients and pharmacies. Here’s how to evaluate risk and find the right technology partner to help protect and defend you from cybercriminals.
pharmaphorum
JULY 13, 2022
Verve Therapeutics has started dosing patients in a phase 1b trial of its in vivo gene-editing drug for high cholesterol, designed to permanently switch off the PCSK9 gene with a one-shot treatment. The heart-1 study is enrolling patients with an inherited form of very high cholesterol – heterozygous familial hypercholesterolaemia (HeFH) – that predisposes them to early development of heart disease.
Pharmacy Times
JULY 13, 2022
A booster dose of both Omicron-adapted vaccine candidates elicited a substantially higher immune response against Omicron BA.1.
pharmaphorum
JULY 13, 2022
Neurodegenerative diseases like Parkinson’s and Alzheimer’s affect millions of people worldwide, and their prevalence is only increasing, according to the World Health Organization. And while pharma companies are working hard to find treatments for these diseases, they have a major problem that must be addressed before that work can be done effectively: the lack of objective, quantitative measurement tools for assessing the progression – or even the presence or absence – of these conditions.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JULY 13, 2022
From the first approved CAR T therapy for multiple myeloma, to the recently-approved ciltacabtagene autoleucel, significant steps have been taken.
European Pharmaceutical Review
JULY 13, 2022
Afrigen Biologics and the US National Institute of Allergy and Infectious Diseases (NIAID) have agreed to share technical expertise related to the development of next-generation messenger RNA (mRNA) vaccines and therapeutics. . “The pursuit of effective vaccines for human diseases to improve public health is central to the mission of the NIAID Vaccine Research Center.
Pharmacy Times
JULY 13, 2022
CS Family Pharmacy has migrated to a combo-type pharmacy, integrating long term care.
Outsourcing Pharma
JULY 13, 2022
The contract development and manufacturing organization has begun fulfilling customer orders at its new clinical manufacturing facility in Rankweil, Austria.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
JULY 13, 2022
Moderna is completing regulatory submissions for mRNA-1273.214 in preparation for the fall booster season, based on clinical data showing that the booster candidate has a significantly higher neutralizing antibody response against all tested variants including Omicron BA.4/5.
Pharma Tutor
JULY 13, 2022
A REVIEW ON COMPUTER AIDED DRUG DESIGN (CAAD) AND IT’S IMPLICATIONS IN DRUG DISCOVERY AND DEVELOPMENT PROCESS. About Authors. Ms. Priti B. Savant,Ms. Ashwini R. Pawar, Ms. Kaufiya D. Sayyed , Ms. Pooja R. Yelmar. 1,2,3,4 Sahyadri College of Pharmacy Methwade Tal, Sangola, Distsolapur Maharashtra 413307. admin. Wed, 07/13/2022 - 15:34. Tags. Articles.
Pharmacy Times
JULY 13, 2022
ThermaCare is intended to provide relief from menstrual pain.
Pharmaceutical Technology
JULY 13, 2022
Roche Group member Genentech has expanded the exclusive strategic partnership agreement with Bicycle Therapeutics by exercising its second option to commence a new programme. The initial agreement was signed in February 2020 for discovering, developing and marketing new immuno-oncology therapies based on Bicycle’s bicyclic peptide technology. Under the deal, the companies are working on discovering and conducting pre-clinical development of new immunotherapies based on Bicycle technology against
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
JULY 13, 2022
Saxagliptin (Onglyza) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
pharmaphorum
JULY 13, 2022
Taiwan-based digital health firm Health2Sync has added another big pharma company to the roster of clients for its patient support platform. The latest partner is AstraZeneca, which has signed up with Health2Sync to develop a digital patient management programme for chronic kidney disease (CKD) patients in Taiwan. The digital health firm is also working with Sanofi, Novo Nordisk and Abbott on diabetes support tools, but this is its first project in the CKD arena.
Pharmacy Times
JULY 13, 2022
The FDA has approved fam-trastuzumab deruxtecan-nxki (Enhertu) for previously treated HER2-positive breast cancer and gastric or gastroesophageal junction adenocarcinoma.
BuzzRx
JULY 13, 2022
Your biggest asset is your well-being - your creativity, ability to manage your time and staff, your mental health and capacity to handle all the changes and decisions required of you all stem from it. Physiological problems sit highest on the list. According to one study , entrepreneurs are twice as likely as the general population to experience Depression, three times as likely to suffer from addiction and six times as likely to struggle with ADHD.
Pharmacy Times
JULY 13, 2022
Each technology should be evaluated on its own merit and, importantly, in appropriate context for your organization given other resources.
DiversifyRx
JULY 13, 2022
Patient testimonials are a powerful tool to help you gain new patients and increase your pharmacy profits. Getting More Conversions From Testimonials. Is growing your pharmacy a goal? Then getting more testimonials should be on your to-do list. One of the best ways to do this is through social proof, aka testimonials. Our conscious and subconscious minds are constantly influenced by the people around us, even if we don’t realize it.
Aureus Medical Group
JULY 13, 2022
Dreaming of ocean breezes for your next summer travel assignment? Avoid crowded beaches and long lines at popular tourist destinations and plan your next Aureus travel assignment around these six charming U.S. beach towns. From delicious food, whimsical streets, and breathtaking views, to exhilarating outdoor adventures, you’ll quickly fall in love with these seaside gems.
Digital Pharmacist
JULY 13, 2022
Social media is a powerful tool that when used properly can reach a wide audience. In today’s blog, we will teach you ways to utilize social media to promote summer health to your patients and community of followers. Creating Eye-Catching Social Media Posts. Be low are two great resources for creating posts and images. Canva ( canva.com ) is an excellent resource to create bright eye-catching designs.
Outsourcing Pharma
JULY 13, 2022
The contract development and manufacturing organization's active pharmaceutical ingredient manufacturing operation is located at its site in Aurora, Canada.
Pharmaceutical Commerce
JULY 13, 2022
Janssen, BMS, and Pfizer round out the top three.
Outsourcing Pharma
JULY 13, 2022
A representative from life-science services company Azzur Group explains how flexibility and speed can help in reaching the best solution more efficiently.
Pharmaceutical Technology
JULY 13, 2022
The proportion of pharmaceutical companies hiring for digitalization related positions rose in June 2022 compared with the equivalent month last year, with 55.1% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 47.3% of companies who were hiring for digitalization related jobs a year ago but a decrease compared to the figure of 57.5% in May 2022.
pharmaphorum
JULY 13, 2022
Merck & Co has added another clinical-stage drug to its oncology pipeline via a licensing agreement with Finland’s Orion for ODM-208, a prostate cancer candidate currently in phase 2 testing. Merck – known as MSD outside the US and Canada – is paying $290 million upfront for global co-development and co-marketing rights to ODM-208, a steroid synthesis inhibitor, as well as follow-up compounds in the same class.
Pharma Times
JULY 13, 2022
Changes to vocational BTEC healthcare qualifications could see reduction in new nurse recruits
Med Ed 101
JULY 13, 2022
In part 2 of our series on CDAI basics in Crohn’s disease, I wanted to cover moderate to severe Crohn’s disease and how treatment may look a little different. As a quick refresher, CDAI stands for Crohn’s Disease Activity Index and as you can imagine it is a scoring system that provides an assessment of […]. The post CDAI Basics and Moderate to Severe Crohn’s – Part 2 appeared first on Med Ed 101.
Expert insights. Personalized for you.
264 
Let's personalize your content